Document Classification

Section Type: RESULTS

Text: In the subgroup of patients with valid ambulatory BP (ABP) recordings and metabolic syndrome (olmesartan, n = 182 ; ramipril, n = 170), the reduction in mean 24-h ABP was greater with olmesartan (SBP 10. 2 mmHg ; 95 % CI 11. 8, 8. 6 ; DBP 6. 6 mmHg ; 95 % CI 7. 5, 5. 6) than with ramipril (SBP 8. 5 mmHg ; 95 % CI 10. 2, 6. 9 ; DBP 4. 7 mmHg ; 95 % CI 5. 7, 3. 7), with a statistically significant (p < 0. 01) difference for the DBP comparison.